THE COMBINED ROLE OF HERBAL THERAPY IN THE PREVENTION OF URINARY TRACT INFECTIONS DURING PROSTATE BIOPSY
https://doi.org/10.21886/2308-6424-2017-5-1-37-41
Abstract
Introduction. Prostate biopsy is a routine method for diagnosing prostate cancer. However, there are a number of serious complications associated with this procedure, and especially development of infection.
Objective. Evaluation of the effectiveness of complex herbal therapy in the prevention of infectious complications in patients exposed to prostate biopsy.
Materials and methods. The study included 40 patients aged 48 to 69 years who underwent prostate biopsy. Patients with chronic prostatitis (category 4 NIH) were divided into two groups. Patients in the comparison group limited to standard antibiotic therapy, and the patients of the main group additionally received Canephron N. The efficacy of the therapy was evaluated at 1, 2 and 6 months after the start of treatment by the dynamics of leukocyte count in prostate secretion and bacterial contamination, prostate- specific atigen (PSA) level, questionnaire data, ultrasound and urodynamic survey methods.
Results. The level of PSA compared to baseline data, decreased by 56.9% in the comparison group and by 67.6% in the main group (p<0.05). A clinically significant bacterial titer and an increase in the number of leukocytes more than10 in sight, were registered in the comparison group in two times more often, than in patients of the main group.
Conclusion. The results of the study make it possible to recommend for patients with chronic prostatitis of category 4 NIH the prescription of Canephron N.
About the Authors
A. V. Il'yashRussian Federation
V. P. Glukhov
Russian Federation
N. E. Avadieva
Russian Federation
S. K. Bedzhanyan
Russian Federation
I. A. Gudima
Russian Federation
A. S. Poliakov
Russian Federation
References
1. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU Int. 2002;89(8):824-8.
2. Zani EL, Clark OA, Rodrigues Netto N Jr. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011;(5):CD006576. doi: 10.1002/14651858.CD006576.pub2
3. de Jesus CM, Correa LA, Padovani CR. Complications and risk factors in transrectal ultrasound-guided prostate biopsies. Sao Paulo Med J. 2006;124(4):198-202.
4. Miura T, Tanaka K, Shigemura K, Nakano Y, Takenaka A, Fujisawa М/ Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature. Int J Urol. 2008;15(5):457-9. doi: 10.1111/j.1442-2042.2007.01975.x
5. Borisov VV, Gordovskaya NB, Shilov E. Phytotherapy drug Kanefron H nephrology practice: present and future. Klinicheskaya nefrologiya. 2010;(6):39-42. (In Russ.)
6. Kulchavenya EV, Breusov A.A. Prevention of exacerbations of chronic Bacterial prostatitis. Urologiya. 2014;(4):50-52. (In Russ.)
7. Neimark Al, Suldina AP, Batanina IA. The application of canephron in complex treatment of chronic pyelonephritis. Rossiyskiy meditsinskiy zhurnal. 2014;20(6):23-26. (In Russ.)
8. Okegawa T, Kinjo M, Ohta M, Miura I, Horie S, Nutahara K, Higashihara E. Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate- specific antigen between 4.1 and 10 ng/mL. IntJ Urol. 2003;10(4):201-6.
9. Xie GS, Lyv JX, Li G, Yan CY, Hou JQ, Pu JX, DingX, Huang YH. Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy. Chin Med J (Engl). 2016;129(15):1800-4. doi: 10.4103/0366-6999.186635
Review
For citations:
Il'yash A.V., Glukhov V.P., Avadieva N.E., Bedzhanyan S.K., Gudima I.A., Poliakov A.S. THE COMBINED ROLE OF HERBAL THERAPY IN THE PREVENTION OF URINARY TRACT INFECTIONS DURING PROSTATE BIOPSY. Urology Herald. 2017;5(1):37-41. (In Russ.) https://doi.org/10.21886/2308-6424-2017-5-1-37-41